Recent Developments in Treatment of Cachexia

作者: Josep M. Argilés , Francisco Javier López-Soriano , Britta Stemmler , Sílvia Busquets

DOI: 10.1007/978-3-319-06151-1_13

关键词:

摘要: The cachexia syndrome, present in severe diseases such as cancer, AIDS and COPD, typically displays metabolic abnormalities, glucose intolerance, fat depletion muscle protein catabolism is usually accompanied by anorexia and, naturally, weight loss. Inflammation also a key feature this situation. Nutritional strategies have proved to be insufficient counteract it. In chapter we review recent therapeutic approaches developed specifically for these wasting states. importance of the right timing stressed, combination with different nutritional/metabolic/pharmacological approaches.

参考文章(39)
Tomíska M, Tomisková M, Salajka F, Vorlícek J, Adam Z, Palliative treatment of cancer anorexia with oral suspension of megestrol acetate. Neoplasma. ,vol. 50, pp. 227- 233 ,(2003)
Ann Dewey, Chris Baughan, Taraneh P Dean, Bernie Higgins, Ian Johnson, Eicosapentaenoic acid (EPA, an omega‐3 fatty acid from fish oils) for the treatment of cancer cachexia Cochrane Database of Systematic Reviews. ,vol. 2007, ,(2007) , 10.1002/14651858.CD004597.PUB2
Josep M. Argilés, Maite Figueras, Elisabet Ametller, Gemma Fuster, Mireia Olivan, Cibely Cristine Fontes de Oliveira, Francisco J. López-Soriano, Robert J. Isfort, Sílvia Busquets, Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells Muscle & Nerve. ,vol. 37, pp. 190- 195 ,(2008) , 10.1002/MUS.20899
Carl G. Kardinal, Charles L. Loprinzi, Daniel J. Schaid, A. Curtis Hass, Ann M. Dose, Laureen M. Athmann, James A. Mailliard, Greg W. McCormack, James B. Gerstner, Mark F. Schray, A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia Cancer. ,vol. 65, pp. 2657- 2662 ,(1990) , 10.1002/1097-0142(19900615)65:12<2657::AID-CNCR2820651210>3.0.CO;2-S
Ronald F. Wolf, Bruce Ng, Benny Weksler, Michael Burt, Murray F. Brennan, Effect of growth hormone on tumor and host in an animal model Annals of Surgical Oncology. ,vol. 1, pp. 314- 320 ,(1994) , 10.1007/BF02303570
Masaki Kanzaki, Kuniyasu Soda, Pham Tien Gin, Toshihiro Kai, Fumio Konishi, Masanobu Kawakami, Erythropoietin attenuates cachectic events and decreases production of interleukin-6, a cachexia-inducing cytokine. Cytokine. ,vol. 32, pp. 234- 239 ,(2005) , 10.1016/J.CYTO.2005.10.002
William J. Evans, John E. Morley, Josep Argilés, Connie Bales, Vickie Baracos, Denis Guttridge, Aminah Jatoi, Kamyar Kalantar-Zadeh, Herbert Lochs, Giovanni Mantovani, Daniel Marks, William E. Mitch, Maurizio Muscaritoli, Armine Najand, Piotr Ponikowski, Filippo Rossi Fanelli, Morrie Schambelan, Annemie Schols, Michael Schuster, David Thomas, Robert Wolfe, Stefan D. Anker, Cachexia: a new definition. Clinical Nutrition. ,vol. 27, pp. 793- 799 ,(2008) , 10.1016/J.CLNU.2008.06.013
James T. Dalton, Kester G. Barnette, Casey E. Bohl, Michael L. Hancock, Domingo Rodriguez, Shontelle T. Dodson, Ronald A. Morton, Mitchell S. Steiner, The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial Journal of Cachexia, Sarcopenia and Muscle. ,vol. 2, pp. 153- 161 ,(2011) , 10.1007/S13539-011-0034-6